These models have demonstrated their effectiveness in several critical aspects of colorectal cancer management, including distinguishing between KRAS gene statuses, assessing tumor grading, and determining MRF invasion by identifying extramural venous invasion. The gene discussed is KRAS; the disease is neoplasm.